For example, TRPA1, TRPC1, TRPV4, TRPV5, and TRPV6 exhibited higher CNV amplification, while TRPV1, TRPV2, TRPV3, and TRPC3 exhibited frequent CNV loss in cancer (Fig. 1e). This evidence concerns the gene TRPV2 and cancer.